LOIM
TGTX icon

Liberty One Investment Management’s TG Therapeutics TGTX Stock Holding History

Liberty One Investment Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-154
Closed -$3.6K – 181
2024
Q3 		$3.6K Sell
154
-839
-84% -$18.3K ﹤0.01% 158
2024
Q2 		$18K Sell
993
-58
-6% -$925 ﹤0.01% 162
2024
Q1 		$16K Sell
1,051
-71
-6% -$1.13K ﹤0.01% 174
2023
Q4 		$19.2K Buy
1,122
+582
+108% +$6.76K ﹤0.01% 141
2023
Q3 		$4.51K Buy
540
+63
+13% +$878 ﹤0.01% 157
2023
Q2 		$11.8K Hold
477
– – ﹤0.01% 139
2023
Q1 		$7.17K Buy
477
+353
+285% +$5.36K ﹤0.01% 158
2022
Q4 		$1.47K Hold
124
– – ﹤0.01% 151
2022
Q3 		$1K Sell
124
-4,585
-97% -$30.1K ﹤0.01% 152
2022
Q2 		$183K Buy
4,709
+4,585
+3,698% +$28.6K 0.03% 125
2022
Q1 		$1K Buy
+124
New +$1.44K ﹤0.01% 168
2021
Q4 		– Sell
-4,697
Closed -$156K – 150
2021
Q3 		$156K Sell
4,697
-12
-0.3% -$371 0.03% 133
2021
Q2 		$183K Buy
4,709
+1,136
+32% +$44.6K 0.03% 136
2021
Q1 		$172K Sell
3,573
-67
-2% -$3.22K 0.03% 127
2020
Q4 		$189K Sell
3,640
-56
-2% -$1.89K 0.04% 108
2020
Q3 		$99K Buy
3,696
+1,431
+63% +$32.9K 0.02% 114
2020
Q2 		$44K Buy
+2,265
New +$36.5K 0.01% 118

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Liberty One Investment Management's TGTX Position: Q4 2024 in Review

Liberty One Investment Management sold out of TG Therapeutics (TGTX) in Q4 2024, closing a stake of 154 shares — an estimated $3.6K sold.

Liberty One Investment Management first reported a position in TGTX in Q2 2020 and held it in 17 quarters. The position peaked at $189K in Q4 2020. 331 funds tracked by Wall St. Rank hold TGTX as of Q4 2024.

  • Liberty One Investment Management reported no remaining TG Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Liberty One Investment Management sold 154 TG Therapeutics shares in Q4 2024, an estimated $3.6K.
  • Liberty One Investment Management first reported a position in TG Therapeutics in Q2 2020 and held it in 17 quarters.
  • Liberty One Investment Management's TG Therapeutics position peaked at $189K in Q4 2020.
  • 331 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2024.

Based on Liberty One Investment Management's 13F filing for Q4 2024, filed 16 Jan 2025.